carbon tetrachloride has been researched along with 3-nitrotyrosine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fan, ST; Fung, ML; Lau, TY; Leung, KM; Leung, TM; Liong, E; Nanji, AA; So, H; Tipoe, GL; Tom, WM | 1 |
Fung, ML; Lau, TY; Leung, TM; Liong, EC; Nanji, AA; Tipoe, GL | 1 |
2 other study(ies) available for carbon tetrachloride and 3-nitrotyrosine
Article | Year |
---|---|
Inhibitors of inducible nitric oxide (NO) synthase are more effective than an NO donor in reducing carbon-tetrachloride induced acute liver injury.
Topics: Alanine Transaminase; Animals; Carbon Tetrachloride; Dinoprost; Immunohistochemistry; Liver; Male; Mice; Mice, Inbred ICR; NF-kappa B; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase Type II; Nitroprusside; Tyrosine | 2006 |
Epigallocatechin-3-gallate (EGCG) reduces liver inflammation, oxidative stress and fibrosis in carbon tetrachloride (CCl4)-induced liver injury in mice.
Topics: Actins; Animals; Anti-Inflammatory Agents; Carbon Tetrachloride; Catechin; Chemical and Drug Induced Liver Injury; Collagen Type I; Cyclooxygenase 2 Inhibitors; Liver Cirrhosis; Male; Matrix Metalloproteinases; Mice; Mice, Inbred C57BL; Nitric Oxide Synthase Type II; Oxidative Stress; Tissue Inhibitor of Metalloproteinases; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha; Tyrosine | 2010 |